Picture of Biostage logo

BSTG Biostage Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Biostage, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.9-7.53-8.33-4.87-7.98
Depreciation
Non-Cash Items1.190.8441.691.130.557
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.701-1.210.373-0.4884.69
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-11-7.64-6.06-4.04-2.63
Capital Expenditures-0.136-0.131-0.129-0.0070
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0640
Sale of Fixed Assets
Cash from Investing Activities-0.136-0.067-0.129-0.0070
Financing Cash Flow Items0.3-0.30
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12.25.025.84.162.84
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.1-2.68-0.3920.1130.216

Or unlock with your email

Or unlock with your email